| |
|
|
|
|
|
|
|||
|
Blood, 8 January 2009, Vol. 113, No. 2, pp. 438-446. Prepublished online as a Blood First Edition Paper on October 24, 2008; DOI 10.1182/blood-2008-04-150789.
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages1 Department of Chemistry, Purdue University, West Lafayette, IN; 2 Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN; 3 Department of Rheumatology, Clarian Arnett Health, Lafayette, IN; and 4 Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN
Previous work has demonstrated that a subset of macrophages expresses a folate receptor (FR) that can mediate internalization of folate-linked molecules, including imaging and therapeutic agents. To characterize this subset, macrophages were collected from peritoneal cavities of mice injected with saline, thioglycolate, zymosan, heat-killed or live bacteria, and cell-surface markers that coexpress with FR were identified. Virtually no F4/80+ peritoneal macrophages from saline-injected mice expressed FR, whereas numerous macrophages from mice injected with each inflammatory stimulus expressed FR. Examination of cell differentiation antigens that are up-regulated in FR+ macrophages revealed markers characteristic of an activated state (CD80, CD86, Ly-6C/G), whereas macrophages lacking these activation markers expressed few or no FR. FR+ macrophages also produced tumor necrosis factor-
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||